A cost-minimization analysis shows significant resource savings associated with the introduction of natalizumab by subcutaneous injection in Sweden, from a socio-economic perspective
MULTIPLE SCLEROSIS JOURNAL（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要